Association between PM(2.5) exposure and blood pressure among young adults in Asia: systematic review and meta-analysis

亚洲青年人群PM2.5暴露与血压的关系:系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND: Ambient air pollution, particularly fine particulate matter (PM(2.5)) and hypertension, are compounding public health challenges in low- and middle-income countries, contributing millions of premature deaths annually. Although several studies have explored the relationship between ambient air pollution and blood pressure, evidence remains limited for young adults. We performed a systematic review and meta-analysis to investigate the magnitude of associations between PM(2.5) exposure and blood pressure among young adults residing in Asia. METHODS: PubMed, Embase, and Scopus were searched for studies published up to December 2024. Eligible studies reported associations between PM(2.5) and blood pressure in populations aged 18–45 years. Data were extracted on study characteristics and effect estimates. Pooled mean changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP) per 10 µg/m³ increase in PM(2.5) were calculated using a random-effects model. Subgroup and sensitivity analyses were performed to explore potential sources of heterogeneity and study influence. RESULTS: Of 177 articles screened, 11 met the inclusion criteria. Overall, each 10 µg/m³ increase in PM(2.5) was associated with a 1.13 mmHg rise in SBP (95% CI: 0.08–2.19) and a 0.38 mmHg rise in DBP (95% CI: − 0.18 to 0.94). Subgroup analysis indicated that long-term exposure was significantly associated with elevated DBP, suggesting a cumulative effect of prolonged PM(2.5) exposure. CONCLUSION: Both short-term and long-term PM(2.5) exposure was positively associated with blood pressure among young adults. These findings highlight novel evidence for overlooked population in previous reviews and underscore the need for targeted interventions and stricter air quality standards to protect cardiovascular health. As the evidence is primarily applicable to East Asian contexts, further research across other Asian regions is needed to establish broader generalizability. TRIAL REGISTRATION: PROSPERO (Registration DOI: PROSPERO 2025 CRD42025642716). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-026-26488-0.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。